Literature DB >> 30466900

Phage Therapy: Going Temperate?

Rodrigo Monteiro1, Diana Priscila Pires1, Ana Rita Costa2, Joana Azeredo3.   

Abstract

Strictly lytic phages have been consensually preferred for phage therapy purposes. In contrast, temperate phages have been avoided due to an inherent capacity to mediate transfer of genes between bacteria by specialized transduction - an event that may increase bacterial virulence, for example, by promoting antibiotic resistance. Now, advances in sequencing technologies and synthetic biology are providing new opportunities to explore the use of temperate phages for therapy against bacterial infections. By doing so we can considerably expand our armamentarium against the escalating threat of antibiotic-resistant bacteria.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas; antibiotic resistance; phage therapy; synthetic biology; temperate phages

Mesh:

Substances:

Year:  2018        PMID: 30466900     DOI: 10.1016/j.tim.2018.10.008

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  45 in total

1.  Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance.

Authors:  Joshua M Borin; Sarit Avrani; Jeffrey E Barrick; Katherine L Petrie; Justin R Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

2.  Prophage Hunter: an integrative hunting tool for active prophages.

Authors:  Wenchen Song; Hai-Xi Sun; Carolyn Zhang; Li Cheng; Ye Peng; Ziqing Deng; Dan Wang; Yun Wang; Ming Hu; Wenen Liu; Huanming Yang; Yue Shen; Junhua Li; Lingchong You; Minfeng Xiao
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

3.  Revealing the mechanism of repressor inactivation during switching of a temperate bacteriophage.

Authors:  Kim Krighaar Rasmussen; Andrés Palencia; Anders K Varming; Habiba El-Wali; Elisabetta Boeri Erba; Martin Blackledge; Karin Hammer; Torsten Herrmann; Mogens Kilstrup; Leila Lo Leggio; Malene Ringkjøbing Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-11       Impact factor: 11.205

4.  Isolation and genomic analysis of temperate phage 5W targeting multidrug-resistant Acinetobacter baumannii.

Authors:  Wenyi Peng; Fei Zeng; Zhiying Wu; Zeyuan Jin; Wanxia Li; Mingzhuo Zhu; Qiuping Wang; Yigang Tong; Lili Chen; Qinqin Bai
Journal:  Arch Microbiol       Date:  2021-12-23       Impact factor: 2.552

5.  DeePhage: distinguishing virulent and temperate phage-derived sequences in metavirome data with a deep learning approach.

Authors:  Shufang Wu; Zhencheng Fang; Jie Tan; Mo Li; Chunhui Wang; Qian Guo; Congmin Xu; Xiaoqing Jiang; Huaiqiu Zhu
Journal:  Gigascience       Date:  2021-09-08       Impact factor: 6.524

Review 6.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

Review 7.  Bacteriophages against enteropathogens: rediscovery and refinement of novel antimicrobial therapeutics.

Authors:  Yrvin León; Christina S Faherty
Journal:  Curr Opin Infect Dis       Date:  2021-10-01       Impact factor: 4.968

8.  Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host.

Authors:  L Blasco; I Bleriot; M González de Aledo; L Fernández-García; O Pacios; H Oliveira; M López; C Ortiz-Cartagena; F Fernández-Cuenca; Á Pascual; L Martínez-Martínez; J Pachón; J Azeredo; M Tomás
Journal:  Antimicrob Agents Chemother       Date:  2022-01-18       Impact factor: 5.938

Review 9.  Viruses with U-DNA: New Avenues for Biotechnology.

Authors:  Kinga K Nagy; Mikael Skurnik; Beáta G Vértessy
Journal:  Viruses       Date:  2021-05-10       Impact factor: 5.048

Review 10.  The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia.

Authors:  Jaclyn G McCutcheon; Jonathan J Dennis
Journal:  Viruses       Date:  2021-06-03       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.